3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Burkitt Lymphoma
2
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
1
Neoplasms
1
Lymphoproliferative Disorders
1
Lymphoma, B-Cell
1
Immunoproliferative Disorders
1
Graft vs Host Disease
1
Bronchiolitis Obliterans Syndrome
1
Interventions
Sunitinib
7
Nivolumab
4
pembrolizumab
3
cabozantinib
2
Ipilimumab
2
Everolimus
2
Axitinib
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
sacituzumab govitecan
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
lenvatinib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
entrectinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
belzutifan
1
avelumab
1
adavosertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Carcinoma, Renal Cell
×
Methotrexate
×
Clear all
No trials found.